3649 results for «218»
3649 results
Is there a rule for DCB in ACS setting?
22 May 2026 – From EuroPCR 2026
This session examines the application of drug-coated balloons (DCB) in the acute coronary syndrome (ACS) setting, comparing outcomes with drug-eluting stents (DES). It discusses the impact of intraluminal thrombus, real-world registry data on DCB-first strategies in STEMI, and multicentre experiences with DCB use in STEMI and...
DCB: what we know and what we do not know
22 May 2026 – From EuroPCR 2026
This session provides a detailed update on drug-coated balloons (DCB) in interventional cardiology, covering the latest clinical data and trials. It identifies scenarios where DCB use is most effective and offers guidance on optimizing procedural techniques to enhance clinical outcomes.
How should I treat my CTO? Adapting to local conditions
22 May 2026 – From EuroPCR 2026
This session delves into managing chronic total occlusions (CTO) under resource-limited conditions, highlighting the essential CTO toolbox and strategic procedural planning. It emphasizes that an antegrade-first approach, often with dual arterial access, can achieve high success in many CTO cases, illustrated through complex real-world cases from...
Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award
20 May 2026 – From EuroPCR 2026
The Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award session celebrates outstanding contributions to cardiovascular research and innovation. It highlights achievements by emerging investigators, recognizing excellence that advances the field of cardiology and inspires future clinical and scientific endeavors.
PCR's Got Talent Award, best abstract & best case Awards
22 May 2026 – From EuroPCR 2026
This session celebrates excellence in interventional cardiology through the PCR's Got Talent Award, highlighting the best abstracts and case presentations. It showcases innovative research and exemplary clinical cases that advance the field, fostering professional recognition and knowledge dissemination.
Personalised Vascular Care Award - Ceremony
20 May 2026 – From EuroPCR 2026
The Personalised Vascular Care Award Ceremony celebrated outstanding achievements in the advancement of personalized vascular treatment approaches, recognizing leaders who have contributed significantly to improving patient outcomes in vascular care.
EuroPCR 2026 Closing Ceremony
22 May 2026 – From EuroPCR 2026
The EuroPCR 2026 Closing Ceremony marks the conclusion of this premier cardiology event, celebrating the latest advances and achievements in interventional cardiology. It offers an opportunity to reflect on the educational sessions, network with peers, and recognize outstanding contributions to the field.
Welcome to EuroPCR 2026
19 May 2026 – From EuroPCR 2026
Welcome to EuroPCR 2026, the premier event for interventional cardiology professionals. This edition offers cutting-edge scientific presentations, live cases, and interactive sessions designed to advance knowledge and clinical practice in cardiovascular interventions.
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)